• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 25VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Hemorrhage/Bleeding (1888)
Event Date 11/13/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical study patient id: (b)(6).It was reported that on (b)(6) 2022, a 25mm masters valve was selected for an implant.Intra-operative bleeding was noted due to complex surgical repair.Post-implant, the patient was transfused 2 units pack red blood cells (prbc), 6 units platelets and 6 units plasma.Heparin was administered with the following activated clotting time (act) levels act's: at 19:45 112 seconds , at 21:15 467 seconds , at 21:30 487 seconds , at 21:45 720 seconds , at 22:15 632 seconds, at 22:45 536 seconds, at 23:45 123 seconds.The patient's international normalized ratio (inr) was pre-op on (b)(6) 1.1, post-op on (b)(6) 1.2, at discharge on (b)(6) 2.5, current on (b)(6) 2.7.The issue was reported to be resolved with sequelae of blood loss anemia with no further treatment planned.The patient remained hemodynamically stable throughout the procedure.The patient was reported to have been discharged home in stable condition.
 
Manufacturer Narrative
An event of intra-operative bleeding due to complex surgical repair was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15895245
MDR Text Key304629397
Report Number2135147-2022-02295
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009492
UDI-Public05414734009492
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/01/2023
Device Model Number25VAVGJ-515
Device Catalogue Number25VAVGJ-515
Device Lot Number8064302
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexMale
Patient Weight50 KG
Patient RaceWhite
-
-